Kura Oncology Inc (KURA)

Deferred Revenue

$55.48M

Quarterly · Period ending: · USD

KURA logo

KURA Deferred Revenue

Latest reported$55.48M
KURA Quarterly Deferred Revenue ($0.00 → $55.48M)
High-resolution chart · PNG

KURA deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kura Oncology Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
55,481,000
47,704,000
48,983,000
48,750,000
49,435,000
40,846,000
24,271,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.